Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a retrospective, multicenter study, consisting of chart review of Saudi Arabian participants diagnosed with breast cancer between 2007 and 2013 and with available human epidermal growth factor receptor 2 (HER2) testing. Data on survival will be collected through 2015.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Participants With Breast Cancer | This study will retrospectively collect data from participants with breast cancer in Saudi Arabia. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Participants With Positive HER2 Test Result | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Participants With Estrogen Receptor/Progesterone Receptor Positive Breast Cancer | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) | |
| Percentage of Participants by Type of First-line and Subsequent Treatment Regimens Used |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Inconclusive, equivocal or unavailable result of HER2/neu overexpression by IHC and FISH
Not provided
Not provided
Not provided
Participants With Early/Metastatic Breast Cancer in Saudi Arabia
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clinical Trials | Hoffmann-La Roche | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| King Fahad Specialist Hospital; Oncology | Dammam | 31444 | Saudi Arabia | |||
| King Faisal Specialist Hospital & Research Centre |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Kaplan-Meier Estimate of Overall Survival (OS) | From January 2007 to December 2015 (Up to 9 years; assessed retrospectively) |
| Kaplan-Meier Estimates of Progression-free Survival (PFS) as Assessed Using Response Evaluation Criteria in Solid Tumors (RECIST) | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Percentage of Participants With Complete Response as Assessed Using RECIST | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Percentage of Participants With Partial Response as Assessed Using RECIST | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Percentage of Participants With Progressive Disease as Assessed Using RECIST | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Percentage of Participants with Stable Disease as Assessed Using RECIST | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Percentage of Participants With Adverse Events | From January 2007 to December 2013 (Up to 7 years; assessed retrospectively) |
| Jeddah |
| 21499 |
| Saudi Arabia |
| National Guard King Abdulaziz Medical City; Oncology | Riyadh | 11426 | Saudi Arabia |
| D017437 |
| Skin and Connective Tissue Diseases |